During the past decade, Itabashi Diabetic medicine and Dermatology Clinic conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 2 clinical trials were completed, i.e. on average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Itabashi Diabetic medicine and Dermatology Clinic" #1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Itabashi Diabetic medicine and Dermatology Clinic" are "Diabetes Mellitus, Type 2" (2 trials). Many other conditions were trialed in "Itabashi Diabetic medicine and Dermatology Clinic" in a lesser frequency.

Most popular intervention types in "Itabashi Diabetic medicine and Dermatology Clinic" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Empa + lina highdose placebo" (1 trials), "Empagliflozin + linagliptin high dose" (1 trials), "Empagliflozin + linagliptin low dose" (1 trials), "Empagliflozin placebo + linagliptin placebo low dose" (1 trials) and "Linagliptin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Itabashi Diabetic medicine and Dermatology Clinic" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Itabashi Diabetic medicine and Dermatology Clinic". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Itabashi Diabetic medicine and Dermatology Clinic, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Itabashi Diabetic medicine and Dermatology Clinic, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".